Legend Biotech Corporation (LEGN)

NASDAQ: LEGN · IEX Real-Time Price · USD

58.74

+0.50 (0.86%)

At close: Jul 19, 2024, 4:00 PM

59.00

+0.26 (0.44%)

Pre-market: Jul 22, 2024, 7:28 AM EDT

Legend Biotech Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Revenue	342.8	285.14	117.01	68.83	75	59.98	Upgrade
Revenue Growth (YoY)	231.84%	143.70%	70.00%	-8.23%	25.04%	22.08%	Upgrade
Cost of Revenue	163.34	144.21	65.36	0	0	0	Upgrade
Gross Profit	179.46	140.93	51.64	68.83	75	59.98	Upgrade
Selling, General & Admin	216.92	200.93	174.05	149.5	72.71	32.37	Upgrade
Research & Development	398.29	382.22	335.65	313.35	232.16	161.94	Upgrade
Other Operating Expenses	-114.02	-58.13	-12.05	-3.06	-6.12	-7.46	Upgrade
Operating Expenses	501.2	525.02	497.65	459.79	298.75	186.86	Upgrade
Operating Income	-321.74	-384.09	-446.01	-390.96	-223.75	-126.88	Upgrade
Interest Expense / Income	22.16	21.79	10.8	0.9	4.21	0.22	Upgrade
Other Expense / Income	124.04	114.23	-11.08	15.33	80.33	0.22	Upgrade
Pretax Income	-467.93	-520.12	-445.72	-407.2	-308.29	-127.32	Upgrade
Income Tax	-1.99	-1.86	0.63	-3.61	-41.91	-25.73	Upgrade
Net Income	-465.95	-518.25	-446.35	-403.58	-266.37	-101.59	Upgrade
Shares Outstanding (Basic)	364	352	318	282	236	200	Upgrade
Shares Outstanding (Diluted)	-	352	318	282	236	200	Upgrade
Shares Change	10.08%	10.71%	12.91%	19.21%	18.15%	-	Upgrade
EPS (Basic)	-2.58	-2.94	-2.80	-2.86	-2.26	-1.02	Upgrade
EPS (Diluted)	-2.58	-2.94	-2.80	-2.86	-2.26	-1.02	Upgrade
Free Cash Flow	-323.2	-460.39	-252.24	-199.53	-259.54	-103.13	Upgrade
Free Cash Flow Per Share	-1.78	-2.62	-1.59	-1.42	-2.20	-1.03	Upgrade
Gross Margin	52.35%	49.42%	44.14%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-93.86%	-134.70%	-381.18%	-568.05%	-298.33%	-211.53%	Upgrade
Profit Margin	-135.92%	-181.75%	-381.48%	-586.38%	-355.16%	-169.37%	Upgrade
Free Cash Flow Margin	-94.28%	-161.46%	-215.58%	-289.91%	-346.06%	-171.95%	Upgrade
EBITDA	-	-477.87	-416.54	-392.38	-294.14	-121.83	Upgrade
EBITDA Margin	-	-167.59%	-356.00%	-570.10%	-392.19%	-203.12%	Upgrade
Depreciation & Amortization	-	20.45	18.39	13.92	9.93	5.26	Upgrade
EBIT	-445.78	-498.32	-434.93	-406.3	-304.08	-127.1	Upgrade
EBIT Margin	-130.04%	-174.76%	-371.72%	-590.32%	-405.43%	-211.90%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).